The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases

We report the identification of ligands for Tyro 3 (alternatively called Sky, rse, brt, or tif) and Axl (alternatively, Ark or UFO), members of a previously orphan family of receptor-like tyrosine kinases. These ligands correspond to protein S, a protease regulator that is a potent anticoagulant, and Gas6, a protein related to protein S but lacking any known function. Our results are reminiscent of recent findings that the procoagulant thrombin, a protease that drives clot formation by cleaving fibrinogen to form fibrin, also binds and activates intracellular signaling via a G protein-coupled cell surface receptor. Proteases and protease regulators that also activate specific cell surface receptors may serve to integrate coagulation with associated cellular responses required for tissue repair and growth, as well as to coordinate protease cascades and associated cellular responses in other systems, such as those involved in growth and remodeling of the nervous system.

[1]  A. Ullrich,et al.  Growth factor signaling by receptor tyrosine kinases , 1992, Neuron.

[2]  B. Dahlbäck.  Protein S and C4b-Binding Protein: Components Involved in the Regulation of the Protein C Anticoagulant System , 1991, Thrombosis and Haemostasis.

[3]  David J. Anderson,et al.  CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130 , 1992, Cell.

[4]  G. Lemke,et al.  Structure, expression, and activity of Tyro 3, a neural adhesion-related receptor tyrosine kinase. , 1994, Oncogene.

[5]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[6]  Nancy Y. Ip,et al.  The α component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development , 1993, Neuron.

[7]  D. Monard.  Tinkering with certain blood components can engender distinct functions in the nervous system. , 1993, Perspectives on developmental neurobiology.

[8]  L. Greene,et al.  Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells , 1993, Neuron.

[9]  C. Basilico,et al.  The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding , 1995, Molecular and cellular biology.

[10]  T. Yamamoto,et al.  brt, a mouse gene encoding a novel receptor-type protein-tyrosine kinase, is preferentially expressed in the brain. , 1994, Oncogene.

[11]  C. Basilico,et al.  A putative receptor tyrosine kinase with unique structural topology. , 1991, Oncogene.

[12]  G. Lemke,et al.  An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system , 1991, Neuron.

[13]  José A Fernández,et al.  Protein S, an Antithrombotic Factor, Is Synthesized and Released by Neural Tumor Cells , 1993, Journal of neurochemistry.

[14]  G. Yancopoulos,et al.  Trkl3 mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor , 1991, Cell.

[15]  G. Gasic,et al.  Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Pawson,et al.  Molecular characterization of a family of ligands for eph‐related tyrosine kinase receptors. , 1994, The EMBO journal.

[17]  M. Goldfarb,et al.  Human oncogenes detected by a defined medium culture assay. , 1987, Oncogene.

[18]  H. Snodgrass,et al.  Cloning and Mrna Expression Analysis of a Novel Human Protooncogene, C-merr , 2022 .

[19]  C. Pegelow,et al.  Severe protein S deficiency in a newborn. , 1992, Pediatrics.

[20]  C. Schneider,et al.  The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade , 1993, Molecular and cellular biology.

[21]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[22]  G. Yancopoulos,et al.  Neurotrophic Factor Receptors and Their Signal Transduction Capabilities in Rat Astrocytes , 1994, The European journal of neuroscience.

[23]  P. Delmas,et al.  Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. , 1992, Endocrinology.

[24]  D. O'reilly,et al.  Baculovirus expression vectors: a laboratory manual. , 1992 .

[25]  G. Long,et al.  Binding of protein S to C4b-binding protein. Mutagenesis of protein S. , 1992, The Journal of biological chemistry.

[26]  R. Espinosa,et al.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase , 1991, Molecular and cellular biology.

[27]  H. Pan,et al.  Molecular cloning of a novel receptor tyrosine kinase, tif, highly expressed in human ovary and testis. , 1994, Oncogene.

[28]  A. Schulz,et al.  A novel putative tyrosine kinase receptor with oncogenic potential. , 1991, Oncogene.

[29]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[30]  M. Hessing.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system. , 1991, The Biochemical journal.

[31]  T Pawson,et al.  Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. , 1994, Science.

[32]  A. Chuansumrit,et al.  Homozygous protein S deficiency in an infant with purpura fulminans. , 1990, The Journal of pediatrics.

[33]  T. Nakamura,et al.  Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Coughlin.  Thrombin Receptor Structure and Function , 1993, Thrombosis and Haemostasis.

[35]  Yosef Yarden,et al.  B61 is a ligand for the ECK receptor protein-tyrosine kinase , 1994, Nature.

[36]  K. Maruyama,et al.  Transfer of functional EGF receptors to an IL3‐dependent cell line , 1988, Journal of cellular physiology.

[37]  K. Kuma,et al.  Cloning of the cDNA for a novel receptor tyrosine kinase, Sky, predominantly expressed in brain. , 1994, Oncogene.

[38]  J. Flanagan,et al.  Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases , 1994, Cell.

[39]  A. Goddard,et al.  rse, a novel receptor-type tyrosine kinase with homology to Axl/Ufo, is expressed at high levels in the brain. , 1994, The Journal of biological chemistry.

[40]  D. Monard,et al.  Prothrombin mRNA is expressed by cells of the nervous system , 1991, Neuron.

[41]  S. Loefas,et al.  Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. , 1991, Analytical biochemistry.

[42]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[43]  H. Hanafusa,et al.  The proto-oncogene of v-eyk (v-ryk) is a novel receptor-type protein tyrosine kinase with extracellular Ig/GN-III domains. , 1994, The Journal of biological chemistry.